As Samsung and Others Push the Envelope on Camera Tech, Chip Suppliers Benefit
Samsung's Galaxy S11 will reportedly have a very powerful rear-camera system. And rivals aren't standing still, either.
Here Are 2 Fantastic Looking Charts
Qorvo topped my scans and all cylinders are firing on Freshpet.
Jobs Numbers Jolt Both Bears and Bulls
The recovery has now occurred so fast that the bulls did not act quickly enough and are again struggling with Fear of Missing Out.
Ulta's Q3 Is Strong Enough With Guidance That It Should Put Buyers in the Stock
As far as the technical picture, momentum traders have to be drooling at this gap fill.
Despite EPS Beat, Ulta Beauty Just Doesn't Look That Good
With competition from the likes of Sephora and slow revenue growth, ULTA seems to be losing its shine, but here's how to play it.
Jim Cramer: Let's Win the Trade War With China
If the Chinese really want a substantive deal, they must renounce their ways and start playing fair with our nation.
4 More Unloved Stocks Going Into My Latest Tax-Loss Selling Portfolio
We'll track a dozen beaten-up stocks that could be subject to tax-loss selling at the end of 2019 to see whether they can stage comebacks in 2020.
Market's Response to Jobs Report Doesn't Change Our Cautionary Outlook
The S&P 500 appears to be at fair value, which makes us wary of buying into a market when more insiders are selling.
Watch These 2 Transport Stocks With Hong Kong Set to Rally
Is the Hong Kong market poised to jump 40%? Its happened before. Transport stocks have suffered more than any due to the city's disruption, and would lead that charge.
Putting My Covered Call Strategy to Work With 2 Dinged Biotech Stocks
Sharp drops in Heron Therapeutics and Supernus Pharmaceuticals have presented opportunities to make lemonade out of lemons.